Comparison between Clinitech Laboratory IPO and Kataria Industries IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Kataria Industries IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | Kataria Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Interactive Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Mnm Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the Kataria Industries IPO is up to ₹51.81 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of Kataria Industries IPO is ₹96.00 per share.
| Clinitech Laboratory IPO | Kataria Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹91.00 per share | |
| Issue Price (Upper) | ₹96.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹96.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 5,71,200 shares | 53,96,400 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹51.81 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 53,96,400 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹51.81 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while Kataria Industries IPO opens on Jul 16, 2024. The closing date of Clinitech Laboratory IPO and Kataria Industries IPO is Jul 29, 2024, and Jul 19, 2024, respectively.
| Clinitech Laboratory IPO | Kataria Industries IPO | |
|---|---|---|
| Anchor Bid Date | Jul 15, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 16, 2024 |
| Issue Close | Jul 29, 2024 | Jul 19, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 22, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 23, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 23, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Jul 24, 2024 |
| Anchor Lockin End date 1 | Aug 21, 2024 | |
| Anchor Lockin End date 2 | Oct 20, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to Kataria Industries IPO P/E ratio of 15.18.
| Clinitech Laboratory IPO | Kataria Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| Kataria Industries Limited Financial Information (Restated Consolidated)Kataria Industries Limited's revenue increased by 2.26% and profit after tax (PAT) rose by 28.83% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.63 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 15.18 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹206.71 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 24.53% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.40% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 1.38 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹6.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 22.03% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in Kataria Industries IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 10,80,000 shares in Kataria Industries IPO.
| Clinitech Laboratory IPO | Kataria Industries IPO | |
|---|---|---|
| Anchor Investor Reserveration | 16,17,600 shares | |
| Market Maker Reserveration | 31,200 shares | 2,88,000 shares |
| QIB | 10,80,000 shares | |
| NII | 2,85,600 shares | 8,10,000 shares |
| RII | 2,85,600 shares | 18,88,800 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 53,96,400 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas Kataria Industries IPO subscribed 393.87x.
| Clinitech Laboratory IPO | Kataria Industries IPO | |
|---|---|---|
| QIB (times) | 171.04x | |
| NII (times) | 23.28x | 970.17x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 274.61x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 393.87x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
